Zeria Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zeria Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
CMIC Holdings Co Ltd
sales of 65.28 billion Japanese Yen [US$590.80 million]
of which 52%
was Cro Business),
Aska Pharmaceutical Company Limited
(48.53 billion Japanese Yen [US$439.17 million]
of which 91%
was Pharmaceutical Products Business), and
Iwaki & Co., Ltd.
(57.39 billion Japanese Yen [US$519.36 million]
Zeria Pharmaceutical Co Ltd reported sales of ¥64.85 billion (US$586.89 million)
March of 2017.
increase of 3.8%
versus 2016, when the company's sales were ¥62.48 billion.
Sales of Consumer Healthcare Business saw an increase
5.3% in 2017, from
¥28.74 billion to ¥30.28 billion.
Not all segments of Zeria Pharmaceutical Co Ltd experienced an increase in sales in 2017:
sales of Other fell 6.8% to ¥142.13 million.
(However, this segment's sales were only a very small portion of the company's overall sales).